Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Comprehensive Analysis of CD163 as a Prognostic Biomarker and Associated with Immune Infiltration in Glioblastoma Multiforme.

BioMed research international - 1 Jan 2021

Li Hao, Wang Di, Yi Bolong, Cai Heng, Xi Zhuo, Lou Xin, Li Zhen

Abstract excerpt

BACKGROUND: Glioblastoma multiforme (GBM) is the most common and aggressive primary malignancy in adults with high aggression. The prognosis of GBM patients is poor. There is a critical need for novel biomarkers for the prognosis and therapy of GBM. METHODS: Differentially expressed genes (DEGs) in GBM were screened using TCGA cohort. Univariate and multivariate Cox regression analyses were performed on DEGs to...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antigens, Differentiation, Myelomonocytic
Share to CD163 Antigen

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Chitinases

Share to Gene Regulatory Networks

Share to Glioblastoma

Share to Lymphocyte Specific Protein Tyrosine Kinase p56(lck)

Share to Protein Interaction Maps

Share to Receptors, Cell Surface

Source

Open in PubMed Open full text

Identifiers

PMID: 34395626
DOI: 10.1155/2021/8357585
PMCID: PMC8363458

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Comprehensive Analysis of CD163 as a Prognostic Biomarker and Associated with Immune Infiltration in Glioblastoma Multiforme.PMID 34395626Read ↗

Molecular and clinical characterization of CD163 expression via large-scale analysis in gliomaSemantic proximity Read ↗

Identification of a Novel Eight-Gene Risk Model for Predicting Survival in Glioblastoma: A Comprehensive Bioinformatic AnalysisSemantic proximity Read ↗

RRN3P2, RPL7AP64, ACTR3C, & RPL7AP30 as Novel Prognostic Biomarkers for Glioblastoma (GBM): A Bioinformatics-Based AnalysisSemantic proximity Read ↗

Identification of an Immune-Related Prognostic Risk Model in GlioblastomaSemantic proximity Read ↗

Identification of Immune-Related lncRNA Prognostic Signature and Molecular Subtypes for GlioblastomaSemantic proximity Read ↗

RRN3P2, RPL7AP64, ACTR3C, & RPL7AP30 as Novel Prognostic Biomarkers for Glioblastoma (GBM): A Bioinformatics-Based AnalysisSemantic proximity Read ↗

Identification of Biomarkers Related to Prognosis of Glioblastoma and Their Correlation with Immune Infiltration CellsSemantic proximity Read ↗

Predictive Analyses of Prognostic-Related Immune Genes and Immune Infiltrates for GlioblastomaSemantic proximity Read ↗

Identification of an Immune-Related Prognostic Signature for Glioblastoma by Comprehensive Bioinformatics and Experimental AnalysesSemantic proximity Read ↗

Identification of novel prognostic targets in glioblastoma using bioinformatics analysisSemantic proximity Read ↗

Bioinformatics analyses of significant genes, related pathways and candidate prognostic biomarkers in glioblastomaSemantic proximity Read ↗

Identification of Candidate Genes Associated With Prognosis in GlioblastomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.